This new partnership will help Howard University, which serves a predominantly Black patient population, forge the path to advance dermatological science and improve representation of Black people leading clinical trials.

To help close the existing racial inequity gap in dermatological research, CeraVe is establishing a fund at Howard University to help its faculty further their expertise and build the infrastructure needed to conduct clinical trials with a focus on skin of color.

Located in Washington D.C, Howard University is one of the only historically Black universities with dermatology department.

Not only do Black physicians account for just 3 percent of dermatologists, despite comprising close to 13 percent of the US population2, the National Center for Science and Engineering Statistics reports that the Black population is consistently underrepresented in science and engineering (S&E) education and employment. A 2011 Science study by Ginther et al. identified a gap in scientific funding, showing that Black researchers are 10 percent less likely to obtain funding than their White counterparts.. Diversity is not just lacking in those participating in clinical trials, but also in those conducting the trials.

However, inclusion of people of color in research and clinical trials is imperative to understand how skin conditions impact this patient population differently, which will lead to the development of efficacious products for skin of color, as well as education for companies and doctors to better serve this patient population.

This new partnership will help Howard University, which serves a predominantly Black patient population, forge the path to advance dermatological science and improve representation of Black people leading clinical trials.

The Partnership with Howard University

The first stage of the partnership between CeraVe and Howard University, will help fund faculty education to obtain certification to conduct clinical trials. By partnering with the Howard University Dermatology Department, CeraVe is helping the University become a leader in research and innovation of dermatological science for skin of color.

"The creation of the fund in partnership with CeraVe allows us to invest in training our academic faculty to conduct clinical research trials, the first step towards building a dermatology clinical trials unit in the only dermatology department at a historically Black university," says Dr. Ginette Okoye, Chair of Dermatology at Howard University College of Medicine.,: in a news release. “The brand's vision and support of the department of dermatology at Howard University improves the retention, and ultimately the academic promotion, of faculty from groups underrepresented in medicine, and by extension provides more opportunities for mentorship of UIM students and residents."

"Equity within skincare is more than representation in marketing and advertising. It is representation of all people at the root of product development," adds Tom Allison, CeraVe co-founder and Senior Vice President of Global Professional Marketing. "To truly achieve therapeutic skincare for all, people of all skin types and tones must be part of skincare research, and this fund at Howard University is one step towards closing the inequity gap."

The funding from CeraVe will cover training for faculty from the Department of Dermatology at Howard University College of Medicine to become certified to lead clinical trials, a critical and groundbreaking step in advancing